SGLT2 INHIBITORS MARKET EXPANSION: PIPELINE UPDATES AND GROWTH PROSPECTS

The SGLT2 inhibitors market continues to expand significantly, primarily due to the increasing prevalence of type 2 diabetes and the growing demand for effective therapies in managing cardiovascular and renal conditions. Sodium-glucose co-transporter-2 (SGLT2) inhibitors have become a crucial therapeutic class known for reducing blood sugar levels